Liu et al. [48] demonstrated that ShenKang injection mitigated AGEs-induced oxidative stress damage in HK-2 cells and enhanced DKD by activating the Keap1/Nrf2/Ho-1 signaling pathway. This evidence concerns the gene KEAP1 and diabetic kidney disease.